Rafferty Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.56M | Sell |
199,758
-15,670
| -7% | -$200K | 0.01% | 557 |
|
|
2025
Q4 | $1.94M | Buy |
215,428
+32,337
| +18% | +$445K | 0.01% | 652 |
|
|
2025
Q3 | $3.16M | Buy |
183,091
+54,298
| +42% | +$669K | 0.01% | 537 |
|
|
2025
Q2 | $1.21M | Sell |
128,793
-51,299
| -28% | -$421K | ﹤0.01% | 726 |
|
|
2025
Q1 | $1.28M | Sell |
180,092
-75,112
| -29% | -$759K | 0.01% | 686 |
|
|
2024
Q4 | $2.98M | Sell |
255,204
-344
| -0.1% | -$5.37K | 0.01% | 528 |
|
|
2024
Q3 | $5.25M | Buy |
255,548
+30,336
| +13% | +$699K | 0.02% | 412 |
|
|
2024
Q2 | $5.04M | Sell |
225,212
-98,349
| -30% | -$2.34M | 0.02% | 413 |
|
|
2024
Q1 | $8.9M | Sell |
323,561
-5,437
| -2% | -$151K | 0.03% | 307 |
|
|
2023
Q4 | $10M | Buy |
328,998
+77,873
| +31% | +$2.24M | 0.04% | 278 |
|
|
2023
Q3 | $7.94M | Buy |
251,125
+42,757
| +21% | +$1.66M | 0.05% | 287 |
|
|
2023
Q2 | $8.5M | Sell |
208,368
-3,020
| -1% | -$122K | 0.05% | 246 |
|
|
2023
Q1 | $7.88M | Sell |
211,388
-23,076
| -10% | -$905K | 0.05% | 249 |
|
|
2022
Q4 | $8.18M | Buy |
234,464
+104,805
| +81% | +$4.98M | 0.07% | 253 |
|
|
2022
Q3 | $7.26M | Buy |
129,659
+13,740
| +12% | +$852K | 0.08% | 207 |
|
|
2022
Q2 | $6M | Buy |
115,919
+26,198
| +29% | +$1.33M | 0.06% | 253 |
|
|
2022
Q1 | $6.52M | Buy |
89,721
+41,867
| +87% | +$3.55M | 0.04% | 301 |
|
|
2021
Q4 | $5.66M | Buy |
47,854
+28,463
| +147% | +$3.57M | 0.03% | 338 |
|
|
2021
Q3 | $2.6M | Sell |
19,391
-11,191
| -37% | -$1.69M | 0.02% | 552 |
|
|
2021
Q2 | $4.95M | Sell |
30,582
-20,273
| -40% | -$1.58M | 0.03% | 322 |
|
|
2021
Q1 | $4.08M | Buy |
50,855
+33,351
| +191% | +$2.24M | 0.03% | 334 |
|
|
2020
Q4 | $952K | Sell |
17,504
-64,161
| -79% | -$2.33M | 0.01% | 513 |
|
|
2020
Q3 | $1.62M | Buy |
81,665
+57,319
| +235% | +$1.2M | 0.02% | 474 |
|
|
2020
Q2 | $512K | Buy |
+24,346
| New | +$414K | 0.01% | 707 |
|
|
2020
Q1 | – | Sell |
-45,492
| Closed | -$667K | – | 742 |
|
|
2019
Q4 | $667K | Sell |
45,492
-58,958
| -56% | -$820K | 0.01% | 639 |
|
|
2019
Q3 | $1.39M | Buy |
104,450
+11,860
| +13% | +$189K | 0.02% | 469 |
|
|
2019
Q2 | $1.52M | Buy |
92,590
+12,871
| +16% | +$202K | 0.03% | 483 |
|
|
2019
Q1 | $1.36M | Buy |
+79,719
| New | +$1.19M | 0.02% | 493 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
